These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 11871510

  • 1. Treatment of chronic hepatitis B.
    Yuen MF, Lai CL.
    Lancet Infect Dis; 2001 Nov; 1(4):232-41. PubMed ID: 11871510
    [Abstract] [Full Text] [Related]

  • 2. Management of viral hepatitis B.
    Pramoolsinsup C.
    J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
    [Abstract] [Full Text] [Related]

  • 3. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N.
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [Abstract] [Full Text] [Related]

  • 4. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
    Dusheiko G.
    Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
    [Abstract] [Full Text] [Related]

  • 5. [New developments in therapy of chronic hepatitis B. When are nucleoside analogs indicated?].
    Petry W, Erhardt A, Heintges T, Häussinger D.
    Z Gastroenterol; 2000 Jan; 38(1):77-87. PubMed ID: 10689749
    [Abstract] [Full Text] [Related]

  • 6. Nucleoside analogues for chronic hepatitis B: antiviral efficacy and viral resistance.
    Papatheodoridis GV, Dimou E, Papadimitropoulos V.
    Am J Gastroenterol; 2002 Jul; 97(7):1618-28. PubMed ID: 12135009
    [Abstract] [Full Text] [Related]

  • 7. Clinical potential of emerging new agents in hepatitis B.
    Farrell GC.
    Drugs; 2000 Oct; 60(4):701-10. PubMed ID: 11085196
    [Abstract] [Full Text] [Related]

  • 8. Treatment of chronic hepatitis B: Evolution over two decades.
    Yuen MF, Lai CL.
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
    [Abstract] [Full Text] [Related]

  • 9. Treatment of chronic hepatitis B: interferon alfa first.
    Prescrire Int; 2001 Feb; 10(51):17-21. PubMed ID: 11503853
    [Abstract] [Full Text] [Related]

  • 10. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W, Król F, Cianciara J, Nazzal K, Gładysz A, Juszczyk J, Bolewska B, Adamek J, Czajka B, Swietek K, Kryczka W, Gonciarz Z.
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [Abstract] [Full Text] [Related]

  • 11. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 12. Treatment of HBeAg-negative chronic hepatitis B.
    Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D.
    Semin Liver Dis; 2003 Feb; 23(1):81-8. PubMed ID: 12616453
    [Abstract] [Full Text] [Related]

  • 13. [Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B].
    Zhou HJ, Li SG, Wen FY, Yang XY, Wu JL, Tan B, Fu J.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):564-8. PubMed ID: 19719911
    [Abstract] [Full Text] [Related]

  • 14. Chronic hepatitis B: a wider range of therapeutic options.
    Prescrire Int; 2007 Aug; 16(90):157-62. PubMed ID: 17724844
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 16. Chronic hepatitis B--treatment with nucleoside analogues.
    Leung N.
    Med J Malaysia; 2005 Jul; 60 Suppl B():22-7. PubMed ID: 16108169
    [Abstract] [Full Text] [Related]

  • 17. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
    Buster EH, Janssen HL.
    Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of lamivudine in HBeAg-negative chronic hepatitis B.
    Rizzetto M.
    J Med Virol; 2002 Apr; 66(4):435-51. PubMed ID: 11857520
    [Abstract] [Full Text] [Related]

  • 19. The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
    Paik YH, Han KH, Hong SP, Lee HW, Lee KS, Kim SO, Shin JE, Ahn SH, Chon CY, Moon YM.
    Antivir Ther; 2006 Apr; 11(4):447-55. PubMed ID: 16856618
    [Abstract] [Full Text] [Related]

  • 20. Treatment of HBe antigen-positive chronic hepatitis B.
    Heathcote J.
    Semin Liver Dis; 2003 Feb; 23(1):69-80. PubMed ID: 12616452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.